Related Experiment Video
Updated: Aug 20, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Related factors of crescents and prognosis in IgA nephropathy
Insights
IgA nephropathy (IgAN) patients with crescents show more severe symptoms and poorer kidney prognosis. Crescents and platelet count are key predictors of IgAN progression.
Area of Science:
- Nephrology
- Glomerular Diseases
- Renal Pathology
Background:
- Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease globally.
- The role of crescents as a predictor of renal prognosis in IgAN remains debated.
- Further research is needed to clarify the significance of crescents in IgAN patients.
Purpose of the Study:
- To investigate the clinical and pathological factors associated with crescents in IgAN.
- To evaluate the prognostic value of crescents for renal function in IgAN patients.
Main Methods:
- 178 IgAN patients were classified into non-crescent (C0) and crescent (C1, C2) groups based on biopsy findings.
- Clinical data, renal pathology indexes, proteinuria, and renal function were compared and followed up.
- Logistic and Cox regression analyses were used to identify risk factors and assess prognosis.
Main Results:
- Crescent groups (C1, C2) exhibited lower serum albumin, hemoglobin, C3, and IgA complements, with higher 24-hour urine protein and erythrocyte counts compared to C0.
- Hemoglobin and C3 complement deposition were independent factors related to crescents.
- Higher crescent proportion (≥25%) and elevated platelet count were associated with significantly worse renal survival and progression to end-stage renal disease.
Conclusions:
- IgAN patients with crescents present with more severe clinical manifestations and a poorer renal prognosis.
- The presence of crescents and elevated serum platelet count are significant risk predictors for adverse outcomes in IgAN.
Background:
IgA nephropathy (IgAN) has the highest prevalence among primary glomerular diseases worldwide, and crescent is a risk predictor of renal prognosis in IgAN. However, this is still controversial, and more research is needed to further confirm the importance of crescents in IgAN patients. So we aim to investigate the related factors and prognosis of IgAN with crescents.
Materials And Methods:
178 patients diagnosed with IgAN by renal biopsy were selected into a crescent group (C group, C1: 0% < crescent proportion < 25%, C2: crescent proportion ≥ 25%) and a non-crescent group (C0 group). The clinical and renal pathology indexes were compared, and the progression of proteinuria and renal function were followed up.
Results:
Compared with the C0 group, the C group revealed lower level of serum albumin, hemoglobin, serum C3, and IgA complements, higher level of 24-hour urine protein quantity and urine erythrocyte count. Statistical differences in the degree of mesangial hyperplasia and C3 complement deposition were found between the two groups. Logistic regression analysis showed that hemoglobin and C3 complement deposition (+ and + +) were independent related factors of crescents in IgAN. Cumulative renal survival rate in C2 was significantly lower than in C1 (χ2 = 5.532, p = 0.019). IgAN patients with more crescents (≥ 25%) (adjusted hazard ratio (AHR) = 4.905, 95% CI: 1.135 - 21.208, p = 0.0033) and platelets (AHR = 1.016, CI: 1.006 - 1.023, p = 0.001) were more likely to progress to the end event in Cox regression analysis.
Conclusion:
IgAN patients with crescents may have severe clinical symptoms and poor prognosis. The crescents and serum platelet count are risk predictors of poor prognosis in IgAN.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management

